Advertisement

Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy

  • F. M. Muggia

Part of the Cancer Treatment and Research book series (CTAR, volume 36)

Table of contents

  1. Front Matter
    Pages i-xii
  2. Concepts

    1. Front Matter
      Pages 1-1
    2. Maurie Markman, Stephen B. Howell
      Pages 39-59
  3. New Drugs and New Clinical Investigation

    1. Front Matter
      Pages 61-61
    2. Gurpreet S. Ahluwalia, Hiremagalur N. Jayaram, David A. Cooney
      Pages 63-102
    3. Jerry M. Collins, Brian Leyland-Jones, Charles K. Grieshaber
      Pages 129-140
    4. Paul P. Trotta, Robert J. Spiegel
      Pages 141-159
    5. Robert H. Earhart
      Pages 161-181
  4. Specific Therapeutic Landmarks

    1. Front Matter
      Pages 183-183
    2. Paul L. Kornblith, Michael Walker
      Pages 185-203
    3. Peter J. O’Dwyer, Brian Leyland-Jones, Daniel F. Hoth
      Pages 233-255
  5. Back Matter
    Pages 257-267

About this book

Introduction

Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good indepth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfor­ tunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by dividing the oncology literature into specific subdivisions such as lung can­ cer, genitourinary cancer, pediatric oncology, etc. Second, by asking emi­ nent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more.

Keywords

DNA Staging Tumor biology cancer treatment cell clinical trial diagnosis interferon pharmacology

Editors and affiliations

  • F. M. Muggia
    • 1
  1. 1.University of Southern California Cancer CentreLos AngelesUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-4613-2061-6
  • Copyright Information Springer-Verlag US 1987
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4612-9224-1
  • Online ISBN 978-1-4613-2061-6
  • Series Print ISSN 0927-3042
  • Buy this book on publisher's site
Industry Sectors
Pharma
Health & Hospitals
Biotechnology